Tech Center 1600 • Art Units: 1617 1627 1642
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18576149 | PREPARATION OF SUBSTITUTED AMIDOXIMES | Non-Final OA | BASF SE |
| 18558423 | TREATMENT OF PHARMACORESISTANT EPILEPSY | Non-Final OA | Katholieke Universiteit Leuven |
| 18071724 | COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT | Non-Final OA | Northwestern University |
| 17895280 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS | Final Rejection | Duke University |
| 18250596 | METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR | Non-Final OA | Arena Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy